SJS Investment Consulting’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
SJS Investment Consulting's PFE Position: Q2 2026 in Review
SJS Investment Consulting increased its Pfizer (PFE) stake by 8.3% in Q2 2026, buying an estimated $11K and bringing the position to 5,482 shares worth $132K. The position accounts for 0.01% of the portfolio, ranked #200.
SJS Investment Consulting first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $248K in Q3 2023. 1,139 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- SJS Investment Consulting held 5,482 shares of Pfizer worth $132K as of Q2 2026.
- SJS Investment Consulting bought 420 Pfizer shares in Q2 2026, an estimated $11K.
- Pfizer made up 0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #200 holding.
- SJS Investment Consulting first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
- SJS Investment Consulting's Pfizer position peaked at $248K in Q3 2023.
- 1,139 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.